13F Holdings
中文EN

ZJYL Jin Medical International Ltd. Annual reports only

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1837821 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-12.0%
TTM net income YoY-67.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR2.5%
Net income 3-yr CAGR-23.9%

Margins

Gross margin29.2%
Operating margin2.9%
Net margin5.8%
FCF margin-18.0%
EBITDA margin4.1%

Returns

ROE4.1%
ROA2.4%
ROIC (approx.)2.5%
Asset turnover0.42x

Leverage & solvency

Liabilities / assets44.6%
Debt / equity0.00x
Current ratio1.86x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.44x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue32.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue$20.69M$23.50M$19.82M$19.19M$20.76M
Cost of revenue$14.64M$14.00M$13.04M$12.99M$14.40M
Gross profit$6.04M$9.50M$6.78M$6.20M$6.36M
R&D expense$1.56M$1.50M$1.54M$1.89M$1.57M
SG&A expense$2.53M$3.26M$1.92M$1.77M$1.67M
Operating income$608,182$3.64M$2.87M$2.13M$2.63M
Pretax income$1.60M$4.18M$3.22M$2.74M$2.88M
Income tax$214,572$763,879$343,707$36,111$248,641
Net income$1.19M$3.68M$2.88M$2.71M$2.63M
EBITDA$851,585$3.88M$3.09M$2.49M$2.98M
EPS (basic)0.010.020.020.020.02
EPS (diluted)0.010.020.020.020.02
Weighted avg. shares (diluted)156.55M156.47M145.14M135.00M135.00M
Banking
Net interest income——$182,682$181,605-$9,492
Balance sheet
Cash & equivalents$7.46M$8.14M$6.93M$4.79M$3.67M
Short-term investments$22.17M$18.62M$9.77M$2.28M—
Receivables$5.81M$5.91M$3.28M$3.83M—
Inventory$4.92M$5.17M$5.05M$6.72M—
Current assets$44.14M$42.82M$31.12M$18.90M—
PP&E, net$7.90M$1.46M$1.48M$1.63M—
Intangibles$1.10M$1.15M$154,364——
Total assets$53.37M$45.80M$32.90M$20.94M—
Current liabilities$23.80M$17.15M$8.92M$5.70M—
Short-term debt$18.84M$11.32M$4.11M——
Total liabilities$23.80M$17.25M$8.92M$5.70M—
Shareholders' equity$29.64M$28.82M$23.98M$15.24M$14.03M
Shares outstanding156.55M155.95M155.95M135.00M—
Cash flow statement
Operating cash flow$2.90M-$1.21M$3.11M$1.58M$5.84M
Capital expenditure$6.63M$144,949$113,937$40,166$42,881
Free cash flow-$3.73M-$1.35M$2.99M$1.54M$5.80M
Investing cash flow-$10.79M-$9.51M-$7.73M-$120,904-$1.07M
Financing cash flow$7.35M$11.65M$6.91M$121,855-$2.87M
Depreciation & amortization$243,403$237,823$225,902$362,597$346,608

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.